Investor insights
Sectors invested in
Life Science2
Biotechnology2
biotechnology1
Medical1
Pharmaceutical1
Therapeutics1
synthetic biology1
RNA therapeutics1
Immunotherapy1
Funding rounds participated in
$27M sweet spot round size
Most of their 3 investments are in rounds between $10M and $27M
Investor type
Private Equity Firm
Venture Capital
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Health Care
targeted therapy and immuno-oncology
Medical
Life Science
Date founded
2010
Investments made
S
Strand Therapeutics raised $52M on June 23, 2021
Investors: Redmile Group, Camford Capital, Playground Global, ANRI and BeiGene
U
Undisclosed raised $10M on March 17, 2021
Investors: BeiGene
L
Leap Therapeutics raised $27M on January 3, 2020
Investors: BeiGene
Funding rounds raised
Total raised
$2.1B
from 6 investors over 6 rounds
B
BeiGene raised $2.1B on July 12, 2020
Investors: Hillhouse Capital Management and GIC
B
BeiGene raised $97M on May 12, 2015
Investors: Hillhouse Capital Management and T. Rowe Price
B
BeiGene raised $75M on November 15, 2014
Investors: CITIC Capital and Hillhouse Capital Management